ctDNA testing post-surgery identifies high-risk stage 3 colon cancer patients more accurately than traditional staging methods. Detectable ctDNA correlates with a four- to six-fold increased risk of ...

A study shows adding immunotherapy to chemotherapy after surgery reduces recurrence and death by half in dMMR stage three ...

While there are several treatment options for colon cancer, not all of them work for all cancer types. Deficient mismatch repair (dMMR) colon cancer is known to be less responsive to chemotherapy than ...

Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped ...

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon cancer have ...

When someone is diagnosed with colorectal cancer—which includes both colon and rectal cancers—many people immediately think ...

Data published in Journal of Clinical Oncology supports routine use of circulating tumor DNA (ctDNA) testing in management of stage III colon cancer patients Researchers found that about 20 percent of ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...

Data published in Journal of Clinical Oncology supports routine use of circulating tumor DNA (ctDNA) testing in management of stage III colon cancer patients Guardant Health, Inc. (Nasdaq: GH), a ...

A large Canadian study found that regular exercise after colon cancer treatment reduces the risk of cancer returning. Patients who followed a structured exercise program had higher survival rates than ...

Imagine popping an over-the-counter pill to remedy a headache. Or taking the same to treat inflammation or arthritis. And all the while, the same common pill is working to cut the risk of colon cancer ...